(Q36497092)

14 August 2017

1 reference

title

Global pharmacogenetics: giving the genome to the masses (English)

1 reference

14 August 2017

Sharon Marsh

1

1 reference

14 August 2017

Derek J Van Booven

series ordinal

2

1 reference

14 August 2017

Howard L McLeod

series ordinal

3

1 reference

14 August 2017

publication date

1 June 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

7

1 reference

14 August 2017

issue

4

1 reference

14 August 2017

page(s)

625-631

1 reference

Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Pharmacogenomics--drug disposition, drug targets, and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

21 January 2018

Cancer pharmacogenetics

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

The PPAR genes, cardiovascular disease and the emergence of PPAR pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Does pharmacogenetics have the potential to allow the individualisation of immunosuppressive drug dosing in organ transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

The pharmacogenetics of antiretroviral therapy: a review of studies to date

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Pharmacogenomics: a path to predictive medicine for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Initial sequencing and analysis of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

A haplotype map of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Pharmacogenetics of irinotecan toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Thymidylate synthase pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Malignant breast tumors after radiotherapy for a first cancer during childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

FDA guidelines on race and ethnicity: obstacle or remedy?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Will tomorrow's medicines work for everyone?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5'-flanking region

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

The human CYP2E1 gene and lung cancer: DraI and RsaI restriction fragment length polymorphisms in a Finnish study population.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

An investigation of whether polymorphisms of cytochrome P4502E1 are genetic markers of susceptibility to alcoholic end-stage organ damage in a chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Genetic determinants of alcohol addiction and metabolism: a survey in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

PstI and RsaI RFLPs in complete linkage disequilibrium at the CYP2E gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Association between polymorphisms of ethanol-metabolizing enzymes and susceptibility to alcoholic cirrhosis in a Korean male population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Genetic polymorphism of cytochrome P4502E1 in a Swedish population. Relationship to incidence of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Genetic polymorphism of cytochrome P450 2E1 in the Turkish population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Genetic polymorphisms in the cytochromes P-450 (1A1, 2E1), microsomal epoxide hydrolase and glutathione S-transferase M1, T1, and P1 genes, and their relationship with chronic bronchitis and relapsing pneumonia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Metabolic genotypes and risk for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Association between CYP2E1 polymorphisms and susceptibility to prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Study of polymorphisms in the CYP2E1 gene in patients with alcoholic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Interaction between a single nucleotide polymorphism in the alcohol dehydrogenase 3 gene, alcohol consumption and oral cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Genetic polymorphisms in three Iranian populations with different risks of esophageal cancer, an ecologic comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Childhood acute lymphoblastic leukemia associated with parental alcohol consumption and polymorphisms of carcinogen-metabolizing genes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Association of cytochrome P450 2E1 genetic polymorphisms with squamous cell carcinoma of the oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Influence of genetic admixture on polymorphisms of drug-metabolizing enzymes: analyses of mutations on NAT2 and C gamma P2E1 genes in a mixed Hispanic population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Arylamine N-acetyltransferase-2 genotypes in the Thai population.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Molecular mechanisms of genetic polymorphisms of drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

The concept of essential medicines: lessons for rich countries

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

25 years of the WHO essential medicines lists: progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Molecular epidemiology of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

Genetic polymorphisms and possible gene–gene interactions in metabolic and DNA repair genes: Effects on DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.7.4.625

21 January 2018

Identifiers

DOI

10.2217/14622416.7.4.625

1 reference

14 August 2017

1 reference